These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12882895)

  • 1. Fenofibrate monotherapy induced rhabdomyolysis.
    Barker BJ; Goodenough RR; Falko JM
    Diabetes Care; 2003 Aug; 26(8):2482-3. PubMed ID: 12882895
    [No Abstract]   [Full Text] [Related]  

  • 2. Fenofibrate monotherapy-induced rhabdomyolysis in a patient with type-2 diabetes.
    Cetinkaya R; Uyanik A; Yildirim R; Bilen Y; Keles M
    Indian J Med Sci; 2008 Nov; 62(11):458-9. PubMed ID: 19265237
    [No Abstract]   [Full Text] [Related]  

  • 3. Simvastatin, fenofibrate, and rhabdomyolysis.
    Jacob SS; Jacob S; Williams C; Deeg MA
    Diabetes Care; 2005 May; 28(5):1258. PubMed ID: 15855605
    [No Abstract]   [Full Text] [Related]  

  • 4. Fenofibrate-induced rhabdomyolysis in a patient with stage 4 chronic renal failure due to diabetes mellitus.
    Soyoral YU; Canbaz ET; Erdur MF; Emre H; Begenik H; Erkoc R
    J Pak Med Assoc; 2012 Aug; 62(8):849-51. PubMed ID: 23862266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rhabdomyolysis induced by fenofibrate monotherapy].
    Archambeaud-Mouveroux F; Lopez S; Combes C; Lassandre S; Amaniou M; Teissier MP; Galinat S
    Rev Med Interne; 2006 Jul; 27(7):573-4. PubMed ID: 16716459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of adverse events with fibrates.
    Alsheikh-Ali AA; Kuvin JT; Karas RH
    Am J Cardiol; 2004 Oct; 94(7):935-8. PubMed ID: 15464682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute renal failure due to fenofibrate monotherapy.
    Usküdar Cansu D; Yaşar NS; Korkmaz C
    Anadolu Kardiyol Derg; 2011 Jun; 11(4):371-2. PubMed ID: 21592934
    [No Abstract]   [Full Text] [Related]  

  • 8. Fenofibrate-induced rhabdomyolysis in two dialysis patients with hypothyroidism.
    Clouâtre Y; Leblanc M; Ouimet D; Pichette V
    Nephrol Dial Transplant; 1999 Apr; 14(4):1047-8. PubMed ID: 10328516
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of rhabdomyolysis complicated with acute renal failure after resumption of fenofibrate therapy: a first report.
    Kiskac M; Zorlu M; Cakirca M; Karatoprak C; Peru C; Erkoc R; Yavuz E
    Indian J Pharmacol; 2013; 45(3):305-6. PubMed ID: 23833382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fenofibrate monotherapy-induced rhabdomyolysis in a patient with hypothyroidism: A rare case report and literature review.
    Wang D; Wang Y
    Medicine (Baltimore); 2018 Apr; 97(14):e0318. PubMed ID: 29620657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenofibrate-induced rhabdomyolysis in a patient with chronic kidney disease: an unusual presenting feature of hypothyroidism.
    Sousa AA; Kronit HS; Neves Fde A; Amato AA
    Arq Bras Endocrinol Metabol; 2009 Apr; 53(3):383-6. PubMed ID: 19578603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothyroidism is a predisposing factor for fenofibrate-induced rhabdomyolysis--patient report and literature review.
    Satarasinghe RL; Ramesh R; Riyaaz AA; Gunarathne PA; de Silva AP
    Drug Metabol Drug Interact; 2007; 22(4):279-83. PubMed ID: 18447003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fixed-dose combination fenofibrate/pravastatin 160/40 mg versus simvastatin 20 mg monotherapy in adults with type 2 diabetes and mixed hyperlipidemia uncontrolled with simvastatin 20 mg: a double-blind, randomized comparative study.
    Farnier M; Steinmetz A; Retterstøl K; Császár A
    Clin Ther; 2011 Jan; 33(1):1-12. PubMed ID: 21397769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thyroid myopathy disclosed by a fibrate].
    Schlienger JL; Goichot B; Grunenberger F; Pradignac A
    Rev Med Interne; 1997; 18(2):169-70. PubMed ID: 9092037
    [No Abstract]   [Full Text] [Related]  

  • 15. Fenofibrate-induced acute renal failure due to massive rhabdomyolysis after coadministration of statin in two patients.
    Unal A; Torun E; Sipahioglu MH; Tokgoz B; Kaya MG; Oymak O; Utas C
    Intern Med; 2008; 47(11):1017-9. PubMed ID: 18520113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antilipemic agents, hypothyroidism, and rhabdomyolysis].
    Pía Iglesias G; Garrido Sanjuán JA; González González C; Sesma Sánchez P
    Rev Clin Esp; 2000 Apr; 200(4):236-7. PubMed ID: 10857417
    [No Abstract]   [Full Text] [Related]  

  • 17. Rhabdomyolysis and acute renal failure associated with gemfibrozil therapy.
    Górriz JL; Sancho A; Lopez-Martin JM; Alcoy E; Catalán C; Pallardó LM
    Nephron; 1996; 74(2):437-8. PubMed ID: 8893176
    [No Abstract]   [Full Text] [Related]  

  • 18. Micronized fenofibrate: a new fibric acid hypolipidemic agent.
    Guay DR
    Ann Pharmacother; 1999 Oct; 33(10):1083-103. PubMed ID: 10534222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fenofibrate-Induced elevation in serum creatinine.
    Ritter JL; Nabulsi S
    Pharmacotherapy; 2001 Sep; 21(9):1145-9. PubMed ID: 11560205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. By the way, doctor. I take Pravachol to control my cholesterol, and because of high triglycerides, my doctor wants to add TriCor. But my pharmacist warns against taking both medications. If I don't take TriCor, are there alternatives?
    Komaroff AL
    Harv Health Lett; 2005 Mar; 30(5):8. PubMed ID: 16528800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.